Actio Biosciences

Acquisition, funding and merger involving Actio Biosciences.

• Actio Biosciences has just announced a $55 Million fundraising (posted on September 14 2023).

View the org chart displaying its 13 main executives

Most searched biographies at Actio Biosciences

• David Goldstein, Chief Executive Officer
• Alex Tkachenko, Director
• Nina Kjellson, Director

Popular executive movements at Actio Biosciences

• Samuel Collins has joined the company as Chief Medical Officer  (posted on January 25 2024).

Create your alert
to follow the executive moves at Actio Biosciences.

Actio Biosciences has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Actio Biosciences

Social media about Actio Biosciences

• Actio Biosciences on Wikipedia, Google News & Yahoo Finance
• Actio Biosciences on LinkedIn, Twitter & YouTube

Contact by email its executives including David Goldstein

Call Actio Biosciences at +32 ...

View the org chart

Register to receive your alert

Report an error